Irinotecan (CPT-11) metabolism and disposition in cancer patients.
Sparreboom A, de Jonge MJ, de Bruijn P, Brouwer E, Nooter K, Loos WJ, van Alphen RJ, Mathijssen RH, Stoter G, Verweij J.
Sparreboom A, et al. Among authors: brouwer e.
Clin Cancer Res. 1998 Nov;4(11):2747-54.
Clin Cancer Res. 1998.
PMID: 9829738
Clinical Trial.